| 1 | [SID17434005] | Active | Potency | 2.6169 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | Potency | 2.6169 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID17434005] | Active | EC50 | 4.097 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | EC50 | 4.097 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 3 | [SID17434005] | Active | EC50 | 4.097 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | EC50 | 4.097 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 4 | [SID17434005] | Active | EC50 | 4.663 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | EC50 | 4.663 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 5 | [SID17434005] | Active | EC50 | 4.663 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | EC50 | 4.663 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 6 | [SID17434005] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17434005] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 8 | [SID17434005] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 9 | [SID17434005] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 10 | [SID17434005] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 11 | [SID17434005] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 12 | [SID17434005] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 13 | [SID17434005] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 14 | [SID17434005] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 15 | [SID17434005] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 16 | [SID17434005] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 17 | [SID17434005] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 18 | [SID17434005] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 19 | [SID17434005] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 20 | [SID17434005] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 21 | [SID17434005] | Active | | | Confirmatory screen for identification of compounds that inhibit transient receptor potential cation channel C6 (TRPC6) [AID488960, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that inhibit transient receptor potential cation channel C6 (TRPC6) | | AID | 488960 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 22 | [SID17434005] | Active | | | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) [AID2553, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) | | AID | 2553 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 23 | [SID17434005] | Active | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 24 | [SID17434005] | Active | | | Specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488927, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488927 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 25 | [SID17434005] | Active | | | Second specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488928, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Active | | BioAssay | Second specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488928 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 26 | [SID17434005] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 27 | [SID17434005] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 28 | [SID17434005] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 29 | [SID17434005] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID17434005] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID17434005] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 32 | [SID17434005] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 33 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 34 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 35 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 36 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 37 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 38 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 39 | [SID17434005] | Inactive | EC50 | 92.48 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | EC50 | 92.48 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 40 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 41 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 42 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 43 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 44 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 45 | [SID17434005] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 46 | [SID17434005] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 47 | [SID17434005] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 48 | [SID17434005] | Inactive | | | High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center. [AID463115, Type: screening] | furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens] [gi:119622516] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center. | | AID | 463115 | | BioAssay type | screening | | Target | furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens] [gi:119622516] | | PubMed | | | Data Table |  |
|
| 49 | [SID17434005] | Inactive | | | High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center. [AID463115, Type: screening] | furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens] [gi:119622516] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center. | | AID | 463115 | | BioAssay type | screening | | Target | furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens] [gi:119622516] | | PubMed | | | Data Table |  |
|
| 50 | [SID17434005] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17434005 | | CID | 2947809 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|